EUROPEAN MEDICAL S news, videos and press releases
For more news please use our advanced search feature.
EUROPEAN MEDICAL S - More news...
EUROPEAN MEDICAL S - More news...
- DMS IMAGING : End of the ongoing procedure with Thierry Legon and reinstatement of the judicial reorganization plan homologated on February 9, 2021.
- Record quarterly revenue: EUR 10.1 million in the 1st quarter of 2023, organic growth +16% - Confirmation of 2023 targets and perspectives
- 2022 revenue: EUR 35.3 m - 2023 targets and perspectives
- Fujifilm Healthcare Italy wins tender for 96 X-ray tables, designed and produced by DMS Imaging
- 2022 bi-annual results
- DMS Imaging: Information on the Total Number of Voting Rights and Shares
- DMS Imaging: Publication Regarding a Transparency Notification
- SQZ Biotechnologies Presents Preclinical Data for their SQZ Tolerizing Antigen Carrier Platform in Antigen-Specific Immune Tolerance (ASIT) Digital Summit Invited Talk
- ASIT biotech Presents Its 2020 Half Year Results and Provides a Business Update Until End 2020
- ASIT biotech Obtains the Benefit of the Judicial Reorganization by Collective Agreement
- ASIT biotech Reintroduces an Application for Judicial Reorganization and Modifies the Composition of Its Board of Directors
- ASIT biotech Discloses Next Steps Following gp-ASIT+TM Phase III Results
- ASIT biotech mode of action study of gp-ASIT+™ for grass pollen allergy published in The Journal of Allergy and Clinical Immunology (JACI)1
- ASIT biotech receives GMP certification for its manufacturing site in Liège, Belgium
- ASIT biotech: Information on the Total Number of Voting Rights and Shares
- ASIT biotech firmly on course for readout of Phase III clinical study in grass pollen allergy
-
Executive interview – ASIT Biotech
-
Executive interview - ASIT Biotech
